Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Postgrad Med J ; 82(968): 411-3, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16754712

ABSTRACT

BACKGROUND: Patients with acute coronary syndrome (ACS) are at high risk of further cardiac events and benefit from early intervention, as reflected by international guidelines recommending early transfer to interventional centres. The current average waiting time of up to 21 days contravenes evidence based early intervention, creates geographical inequity of access, wastes bed days, and is unsatisfactory for patients. METHODS: A regional transfer unit (RTU) was created to expatriate access of ACS patients referred from other centres to the revascularisation service. By redesigning the care pathway patients arriving on the RTU undergo angiography within 24 hours, and then leave the RTU the following day, allowing other ACS patients to be treated. RESULTS: During the first six months of the RTU, the mean waiting time from referral to procedure decreased from 20 (SD 15) days (range 0-51) to 8 (SD 3) days (range 0-21) for 365 patients transferred from a district general hospital. Ninety seven per cent of patients underwent angiography within 24 hours, 61% having undergone percutaneous coronary intervention at the same sitting, and 78% were discharged home within 24 hours. CONCLUSIONS: Delivering standards laid out in the National Service Framework, reducing inequalities of care across the region, and facilitating evidence based strategies of care represents a challenging and complex issue. For high risk patients suffering ACS who need early invasive investigation, a coordinated network wide approach together with the creation of an RTU resulted in a 62% reduction in waiting times for no extra resources. Further improvements can be expected through increased capacity of this verified strategy.


Subject(s)
Coronary Disease/therapy , Angioplasty, Balloon, Coronary/statistics & numerical data , Coronary Angiography , Coronary Artery Bypass/statistics & numerical data , Coronary Disease/diagnostic imaging , Female , Hospitals, District/statistics & numerical data , Humans , Length of Stay , Male , Middle Aged , Patient Transfer , Prognosis , Prospective Studies , Referral and Consultation , Syndrome , Time Factors , United Kingdom , Waiting Lists
2.
Gene Ther ; 13(6): 541-52, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16397510

ABSTRACT

As soon as RNA interference (RNAi) was found to work in mammalian cells, research quickly focused on harnessing this powerful endogenous and specific mechanism of gene silencing for human therapy. RNAi uses small RNAs, less than 30 nucleotides in length, to suppress expression of genes with complementary sequences. Two strategies can introduce small RNAs into the cytoplasm of cells, where they are active - a drug approach where double-stranded RNAs are administered in complexes designed for intracellular delivery and a gene therapy approach to express precursor RNAs from viral vectors. Phase I clinical studies have already begun to test the therapeutic potential of small RNA drugs that silence disease-related genes by RNAi. This review will discuss progress in developing and testing small RNAi-based drugs and potential obstacles.


Subject(s)
Genetic Therapy/methods , RNA Interference , RNA, Small Interfering/therapeutic use , Animals , Drug Administration Schedule , Drug Design , Genetic Engineering , Humans , Models, Animal , RNA, Small Interfering/pharmacokinetics , Randomized Controlled Trials as Topic
3.
Curr Opin Mol Ther ; 3(1): 25-30, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11249728

ABSTRACT

A role for heat shock proteins in eliciting CD8 cytotoxic T-lymphocyte (CTL) responses in the absence of exogenous adjuvants has been documented for some time. Only recently, however, has the mechanism by which these molecules are able to elicit such responses begun to be elucidated.


Subject(s)
Drosophila Proteins , Heat-Shock Proteins/immunology , T-Lymphocytes, Cytotoxic/immunology , Animals , Antigen Presentation , Antigen-Presenting Cells/immunology , Antigen-Presenting Cells/metabolism , Cytokines/biosynthesis , Heat-Shock Proteins/metabolism , Histocompatibility Antigens Class I/metabolism , Humans , Inflammation/etiology , Inflammation/prevention & control , Lipopolysaccharide Receptors/metabolism , Membrane Glycoproteins/metabolism , Receptors, Cell Surface/metabolism , Toll-Like Receptors
4.
Immunity ; 12(3): 263-72, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10755613

ABSTRACT

A 65 kDa mycobacterial heat shock protein (hsp65), fused to a polypeptide that contains an octapeptide (SIYRYYGL) agonist for a particular T cell receptor (2C TCR), stimulated C57BL/6 mice as well as CD4-deficient mice to produce CD8+ cytolytic T lymphocytes (CTL) to the fusion partner's octapeptide. This and other hsp65 fusion proteins but not native hsp65 itself stimulated dendritic cells in vitro and in vivo to upregulate the levels of MHC (class I and II) and costimulatory (B7.2) molecules. The results suggest a mechanism for the general finding that hsp fusion proteins, having fusion partners of widely differing lengths and sequences, elicit CD8 CTL to peptides from the fusion partners without requiring exogenous adjuvants or the participation of CD4+ T cells.


Subject(s)
Antigens, Bacterial/immunology , Bacterial Proteins , Chaperonins/immunology , T-Lymphocytes, Cytotoxic/immunology , Animals , Antigen-Presenting Cells/immunology , CD4-Positive T-Lymphocytes/immunology , Chaperonin 60 , Dendritic Cells/immunology , H-2 Antigens/immunology , Macrophages/immunology , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Recombinant Fusion Proteins/immunology
6.
Int Arch Allergy Immunol ; 116(2): 93-102, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9652301

ABSTRACT

Immunological tolerance is defined as a state of specific non-responsiveness to a particular antigen induced by previous exposure to that same antigen. The mucosal surfaces comprise the upper and lower respiratory tracts, the gastrointestinal tract and the urogenitary tract, and are a major site of antigenic challenge. The immune system associated with the mucosa has the extraordinary potential to discriminate between antigens that are harmless (e.g. inhaled and dietary antigens) and those that are associated with pathogens. Normally soluble proteins delivered through the mucosal surfaces do not elicit a strong systemic immune response but instead induce a transient local immune response that is replaced by long-term peripheral unresponsiveness this is termed mucosal tolerance. The phenomenon of oral tolerance is well established and considerable attention has focussed on defining the underlying mechanisms. However, only comparatively recently was the induction of tolerance via the respiratory mucosa described, and it is this form of mucosal tolerance which forms the basis of this review.


Subject(s)
Immune Tolerance/immunology , Respiratory System/immunology , Humans , Nasal Mucosa/immunology , Respiratory Hypersensitivity/immunology , Th1 Cells/immunology , Th2 Cells/immunology
7.
J Immunol ; 161(1): 175-82, 1998 Jul 01.
Article in English | MEDLINE | ID: mdl-9647222

ABSTRACT

The TCRs expressed on T lymphocytes recognize foreign peptides bound to MHC molecules. This reactivity is the basis of specific immune response to the foreign Ag. How such specificities are generated in the thymus is still being debated. Signals generated through TCR upon interaction with self MHC-peptide complexes are critical for maturation of the CD4+ helper and CD8+ cytotoxic subsets. We have observed maturation of CD4+ but not CD8+ T cells in Ly-6A.2 transgenic MHC null mice. Since there can be no interactions with MHC molecules in these mice, these CD4+ cells must express the T cell repertoire that exists before positive and negative selection. Interestingly, despite an absence of selection by MHC molecules, the CD4+ cells that mature recognize MHC molecules at a frequency as high as in CD4+ cells in normal mice. These results demonstrate that: 1) the germline sequences encoding TCRs are biased toward reactivity to MHC molecules; and 2) CD4+ cells as opposed to CD8+ cells have distinct lineage commitment signals. These results also suggest that signals originating from Ly-6 can promote or substitute for signals generated from TCR that are required for positive selection. Moreover, this animal model offers a system to study T cell development in the thymus that can provide insights into mechanisms of lineage commitment in developing T cells.


Subject(s)
Antigens, CD , Antigens, Ly/genetics , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , Histocompatibility Antigens Class II/biosynthesis , Histocompatibility Antigens Class II/genetics , Histocompatibility Antigens Class I/biosynthesis , Histocompatibility Antigens Class I/genetics , Animals , Antigens, Differentiation/metabolism , CD24 Antigen , CD4-Positive T-Lymphocytes/cytology , CD40 Antigens/metabolism , CD40 Ligand , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/immunology , Cell Differentiation/immunology , Cell Movement/immunology , Down-Regulation/immunology , Histocompatibility Antigens Class I/immunology , Histocompatibility Antigens Class II/immunology , Hot Temperature , Hyaluronan Receptors/biosynthesis , Immunophenotyping , Ligands , Lymphocyte Activation , Lymphoid Tissue/cytology , Lymphoid Tissue/metabolism , Membrane Glycoproteins/metabolism , Mice , Mice, Transgenic , Receptors, Antigen, T-Cell, alpha-beta/biosynthesis , Receptors, Antigen, T-Cell, alpha-beta/genetics , Receptors, Antigen, T-Cell, alpha-beta/metabolism , T-Lymphocyte Subsets/cytology , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Thymus Gland/cytology , Up-Regulation/immunology
8.
Immunol Cell Biol ; 75(2): 148-53, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9107567

ABSTRACT

Peptides that consist of two tandemly repeated epitopes joined by a flexible linker have an increased affinity for class II molecules and are more potent at inducing proliferation of T cell clones than monomeric epitopes. The increase in potency of peptides with two epitopes for individual T cell clones is proportional to the relative CD4 dependence of the clones. We show that epitope dimers activate T cell clones that respond sub-optimally to monomeric epitopes presented by APC from HIV-infected donors. We hypothesize that HIV+ APC normally fail to stimulate the clones because virally encoded gp 120 sequesters CD4 from the activation complex, but epitope dimers overcome this effect because they are better able to recruit CD4. The alpha beta heterodimer of human class II (HLA-DR1) is further ordered as a dimer of heterodimers (superdimer) at least in its crystal form. Since class II molecules have an open-ended antigen binding groove, the superdimer is theoretically permissive of stable binding of two peptide epitopes linked in tandem. Our data support a role for the MHC class II dimer of heterodimers in amplifying the proliferative response of T cells to antigen by dint of the superdimers having a higher affinity for CD4 than the nominal class II alpha beta heterodimers.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Epitopes/immunology , HLA-DR1 Antigen/immunology , Lymphocyte Activation , Antigen-Presenting Cells/immunology , Dimerization , Epitopes/metabolism , HIV Infections/immunology , HLA-DR1 Antigen/metabolism , Humans , Oligopeptides/chemistry , Oligopeptides/immunology , Repetitive Sequences, Nucleic Acid
9.
J Immunol ; 154(9): 4233-9, 1995 May 01.
Article in English | MEDLINE | ID: mdl-7722283

ABSTRACT

Ly-6A.2 is a surface protein on T cells that may play a role in lymphocyte activation. The regulation of Ly-6A.2 expression during T cell lymphopoiesis has been intriguing. It is one of the earliest markers expressed on pluripotent hemopoietic stem cells and is present on both primitive and mature T cells, but its expression is extinguished in the thymus during key developmental stages. To determine whether Ly-6A.2 is active on developing T cells, as well as the significance of its developmental regulation, Ly-6A.2 was expressed throughout T cell development under control of the T cell-specific human CD2 enhancer in transgenic mice. The constitutive overexpression of Ly-6A.2 in vivo led to a marked impairment in the generation of thymocytes. Development was arrested at the time in thymic development when Ly-6A.2 expression is normally turned off. These results indicate that the regulated expression of Ly-6A.2 in thymocytes may be important for normal development. Moreover, these findings demonstrate that Ly-6A.2 is active in the thymic microenvironment.


Subject(s)
Antigens, Ly/biosynthesis , Cell Differentiation/immunology , T-Lymphocytes/immunology , Thymus Gland/embryology , Animals , Antigens, Ly/immunology , Embryonic and Fetal Development/immunology , Flow Cytometry , Gene Expression Regulation, Developmental/immunology , Mice , Mice, Transgenic , T-Lymphocyte Subsets/immunology
10.
Kidney Int ; 42(2): 480-7, 1992 Aug.
Article in English | MEDLINE | ID: mdl-1328754

ABSTRACT

Infiltration of glomerular mesangium by monocytes/macrophages is a prominent pathologic finding in many forms of glomerulonephritis (GN). While the mechanism(s) by which infiltration occurs is incompletely understood, monocyte adhesion to glomerular endothelial cells, provoked by inflammatory mediators, appears to be an important early step. In the present study, we assessed the influence of chemotactic peptides (C5a) and lipids (LTB4 and PAF) on adhesion of human monocytes and mesangial cells, to determine if mesangial cells (glomerular pericytes with smooth muscle properties) represent potential targets for adhesion of chemoattractant-activated monocytes following their diapedesis from the intravascular space. C5a and LTB4 provoked rapid (onset less than 1 min) monocyte-mesangial cell adhesion at nanomolar concentrations via actions with monocytes, while PAF was less potent in this regard. Monoclonal antibodies (mAb) were used to define the monocyte and mesangial cell adhesion molecules involved in these interactions. C5a- and LTB4-induced monocyte adhesion was inhibited (approximately 54%) by mAb against the common beta CD18 subunit of CD11/CD18 leukocyte integrins, while mAb against monocyte L-selectin was without effect. MAb against unique CD11 subunits were used to determine the relative contributions of different CD11/CD18 integrins. In this regard, adhesion was inhibited by mAb against CD11b (approximately 41%), and CD11c (approximately 23%), but not CD11a. MAb against mesangial cell ICAM-1 afforded approximately 27% reduction in adhesion, while mAb against VCAM-1, E-selectin, and P-selectin were without effect. GM-CSF, a cytokine generated by monocytes and mesangial cells, also provoked CD11/CD18-dependent adhesion, and primed monocytes to the actions of chemoattractants.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Glomerular Mesangium/cytology , Monocytes/cytology , Antibodies, Monoclonal , Cell Adhesion/drug effects , Cell Adhesion/physiology , Cells, Cultured , Complement C5a/pharmacology , Cytokines/pharmacology , Glomerular Mesangium/drug effects , Glomerular Mesangium/injuries , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Humans , In Vitro Techniques , Integrins/physiology , Leukotriene B4/pharmacology , Monocytes/drug effects , Monocytes/physiology , Platelet Activating Factor/analogs & derivatives , Platelet Activating Factor/pharmacology
11.
North Hist ; 8: 45-63, 1973.
Article in English | MEDLINE | ID: mdl-11615018
SELECTION OF CITATIONS
SEARCH DETAIL
...